Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR22186-266] to Interferon beta - BSA and Azide free
  • Suitable for: IP, WB
  • Reacts with: Mouse

Overview

  • Product name

    Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free
    See all Interferon beta primary antibodies

  • Description

    Rabbit monoclonal [EPR22186-266] to Interferon beta - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    IP
    Mouse
    WB
    Mouse
    See all applications and species data

  • Immunogen

    Recombinant full length protein. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: RAW 264.7 treated with with 50 µg/ml DMXAA for 7 hours, then with 300 ng/ml Brefeldin A (BFA) added after 1hour, whole cell lysate; RAW 264.7 treated with 100 ng/ml lipopolysaccharide (LPS) for 6 hours, then with 300 ng/ml Brefeldin A (BFA) added after 3 hours, whole cell lysate.

  • General notes

    ab238652 is the carrier-free version of ab218229 This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    Ab238652 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This antibody was developed with support from The Michael J. Fox Foundation.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Immunoprecipitation - Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)
    Immunoprecipitation - Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)

    Interferon beta was immunoprecipitated from 0.35 mg of RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) treated with 50μg/ml DMXAA for 1h, then together with 300ng/ml brefeldin A (BFA) for another 6h whole cell lysate with ab218229 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab218229 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

    Lane 1: RAW 264.7 (treated with DMXAA/BFA) whole cell lysate 10 μg (Input).
    Lane 2: ab218229 IP in RAW 264.7 (treated with DMXAA/BFA) whole cell lysate.
    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab218229 in RAW 264.7 (treated with DMXAA/BFA) whole cell lysate.

    Blocking and dilution buffer and concentration: 5% NFDM/TBST.
    Exposure time: 10 seconds.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab218229).

  • Western blot - Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)
    Western blot - Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)
    All lanes : Anti-Interferon beta antibody [EPR22186-266] (ab218229) at 1/1000 dilution

    Lane 1 : Untreated RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate
    Lane 2 : RAW 264.7 treated with 50 µg/ml DMXAA for 7 hours, then with 300 ng/ml Brefeldin A (BFA) added after 1hour, whole cell lysate
    Lane 3 : Untreated RAW 264.7 whole cell lysate
    Lane 4 : RAW 264.7 RAW264.7 treated with 100 ng/ml lipopolysaccharide (LPS) for 6 hours, then with 300 ng/ml Brefeldin A (BFA) added after 3 hours, whole cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Predicted band size: 22 kDa
    Observed band size: 24,26 kDa
    why is the actual band size different from the predicted?



    Exposure time : Lanes 1 and 2: 26 seconds; Lanes 3 and 4: 3 minutes.

    Blocking/Dilution buffer: 5% NFDM/TBST.

    Interferon beta can be induced to increase the expression by DMXAA or LPS in RAW264.7 cell (PMID: 23027866, PMID: 16020513).

    The doublet is likely due to isoforms (PMID: 7352261).

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab218229).

  • Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)
    Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-Interferon beta antibody [EPR22186-266] - BSA and Azide free (ab238652)

© 2021 Astana Biomed Group LLP. All rights reserved.